Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


TSXV:BTI.H - Post by User

Comment by Sniper007on Jul 03, 2013 7:20pm
162 Views
Post# 21587891

RE:Genentech

RE:Genentech
Beenthere, you’ve beenhere long enough to know there is NO negative news (excluding share price!) and the negative perception re: Shire, has gone away. 
 
Do you think Shire might've been playing hardball with BTI and BTI management told them where to go?  I suspect Shire threatened to walk (or something like that) and BTI called their bluff.  Way to go BTI management, I say.  Personally, I feel great about Shire still being at the dinner table after all the negative speculation that they had walked.  What it says to me is that after over a year and a half that Shire is still very interested in BT2111.  It also lends credibility to RH’s comments that all collaborations are going “very well” and are “meeting expectations”.  I also like the fact that BTI has “shelved Cognitest” to “focus on Transcend”… actually, I LOVE that fact.  I feel “crappy” about the SP but feel great about the near future transactions that should be taking place anytime soon.  Go BTI.  Make us rich.

Bullboard Posts